DS
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study | PLOS ONE |  | 2019 | 466 | 213 | ||
| Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions | Swiss Medical Weekly | | 2019 | 440 | 301 | ||
| Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030? | PLOS ONE | | 2018 | 426 | 203 | ||
| Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review | Journal of Viral Hepatitis |  | 2018 | 531 | 0 | ||
| Visualization of hepatitis E virus RNA and proteins in the human liver | Journal of hepatology | | 2017 | 461 | 0 | ||
| Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland | Clinical Reviews in Allergy & Immunology | | 2017 | 518 | 0 | ||
| Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030 | Swiss Medical Weekly | | 2017 | 939 | 237 | ||
| A Systematic Review and Meta-Analysis of HCV Clearance | Liver international | | 2017 | 601 | 1 | ||
| Trends in hepatitis C-related mortality in Switzerland | Journal of Hepatology | | 2017 | 1,253 | 775 | ||
| Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes | Nature communications | | 2015 | 578 | 164 | ||
| Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland | PloS one | | 2015 | 618 | 1,362 | ||
| Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland | Schweizerische medizinische Wochenschrift | | 2015 | 612 | 247 | ||
| Clinical significance of the CCR5delta32 allele in hepatitis C | PloS one | | 2014 | 586 | 243 | ||
| Historical epidemiology of hepatitis C virus (HCV) in selected countries | Journal of viral hepatitis | | 2014 | 627 | 1 | ||
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm | Journal of viral hepatitis | | 2014 | 596 | 1 | ||
| Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes | Nature communications | | 2014 | 675 | 1,237 | ||
| Strategies to manage hepatitis C virus (HCV) disease burden | Journal of viral hepatitis | | 2014 | 601 | 1 | ||
| Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development | PloS one | | 2013 | 705 | 631 | ||
| Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma | Journal of hepatology | | 2013 | 669 | 0 | ||
| Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection | Gastroenterology | | 2012 | 630 | 0 | ||
| Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma | Schweizerische medizinische Wochenschrift | | 2012 | 561 | 0 |
